This company listing is no longer active
CareTech Holdings Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Wichtige Informationen
29.5%
Wachstumsrate der Gewinne
27.1%
EPS-Wachstumsrate
Healthcare Gewinnwachstum | 21.0% |
Wachstumsrate der Einnahmen | 7.9% |
Zukünftige Eigenkapitalrendite | 13.6% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
9/30/2024 | 615 | 57 | 116 | 95 | 2 |
9/30/2023 | 564 | 51 | 103 | 89 | 3 |
9/30/2022 | 529 | 42 | 91 | 80 | 3 |
3/31/2022 | 495 | 8 | 43 | 78 | N/A |
12/31/2021 | 492 | 20 | 47 | 81 | N/A |
9/30/2021 | 489 | 32 | 52 | 84 | N/A |
6/30/2021 | 477 | 42 | 58 | 88 | N/A |
3/31/2021 | 464 | 52 | 63 | 92 | N/A |
12/31/2020 | 447 | 38 | 61 | 88 | N/A |
9/30/2020 | 430 | 25 | 58 | 84 | N/A |
6/30/2020 | 420 | 25 | 40 | 67 | N/A |
3/31/2020 | 411 | 24 | 23 | 50 | N/A |
12/31/2019 | 403 | 22 | 16 | 45 | N/A |
9/30/2019 | 395 | 20 | 9 | 40 | N/A |
6/30/2019 | 343 | 15 | 11 | 38 | N/A |
3/31/2019 | 291 | 10 | 13 | 37 | N/A |
12/31/2018 | 238 | 10 | 13 | 33 | N/A |
9/30/2018 | 186 | 11 | 13 | 30 | N/A |
6/30/2018 | 180 | 15 | 10 | 28 | N/A |
3/31/2018 | 175 | 19 | 8 | 26 | N/A |
12/31/2017 | 170 | 18 | 5 | 24 | N/A |
9/30/2017 | 166 | 18 | 2 | 22 | N/A |
6/30/2017 | 161 | 19 | 7 | 25 | N/A |
3/31/2017 | 157 | 20 | 11 | 29 | N/A |
12/31/2016 | 153 | 21 | 14 | 30 | N/A |
9/30/2016 | 149 | 23 | 17 | 31 | N/A |
6/30/2016 | 142 | 18 | 17 | 30 | N/A |
3/31/2016 | 134 | 14 | 17 | 30 | N/A |
12/31/2015 | 129 | 11 | N/A | 28 | N/A |
9/30/2015 | 124 | 8 | N/A | 27 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: C5P's forecast earnings growth (29.5% per year) is above the savings rate (-0.01%).
Ertrag vs. Markt: C5P's earnings (29.5% per year) are forecast to grow faster than the German market (9.8% per year).
Hohe Wachstumserträge: C5P's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: C5P's revenue (7.9% per year) is forecast to grow faster than the German market (3.9% per year).
Hohe Wachstumseinnahmen: C5P's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: C5P's Return on Equity is forecast to be low in 3 years time (13.6%).